Latest Shareholder Dilution News

Resource Mining Corporation has locked in a $5 million convertible securities facility to fund its expanding exploration programs across Tanzania, Saudi Arabia, and Finland. The initial $1.3 million drawdown supports ongoing copper-gold drilling and new gold ventures.

Loyal Metals has secured an option to acquire the world-class Highway Reward Copper-Gold Mine and is progressing its North American lithium assets, supported by $3.77 million in funding.

Genmin Limited’s latest quarterly cash flow report reveals significant cash outflows and a critical liquidity shortfall, prompting urgent funding measures including new loans and convertible notes.

The Takeovers Panel has decided not to declare unacceptable circumstances following Keybridge Capital's challenge to Yowie Group's off-market takeover bid, which has now been withdrawn.

Core Lithium has repositioned its Finniss Lithium Project as a low-cost underground operation with a 20-year mine life, slashing operating costs by a third and boosting production capacity. The company is advancing strategic funding while unlocking flexibility through a key offtake agreement termination.

Paradigm Biopharmaceuticals has advanced its global Phase 3 trial for knee osteoarthritis pain with active patient recruitment in Australia and the US, backed by a $41.2 million convertible note facility. The company also expanded its osteoarthritis portfolio through the acquisition of Proteobioactives and the Pentacoxib™ oral therapy.

Patagonia Lithium Ltd has announced a fully underwritten entitlement offer to raise approximately $2.68 million, aimed at advancing its drilling program in Argentina and updating its mineral resource estimates. The offer, supported by major shareholders, reflects confidence in the company’s Formentera Lithium Brine Project.

Koba Resources has issued over 11 million new shares and attached options to fund exploration at its Yarramba Uranium Project, signaling renewed momentum in its uranium ambitions.

Lodestar Minerals has issued a replacement proxy form to correct an omission in its original Notice of Meeting, ensuring shareholders can fully participate in the upcoming General Meeting.

Vanadium Resources Limited has raised A$1.2 million through an oversubscribed placement to support its near-term production ambitions and convert outstanding debt into equity, strengthening its balance sheet.

NOVONIX has entered a multi-tranche funding agreement with Yorkville Advisors to raise up to US$100 million through convertible debentures, supporting its Riverside facility build-out and commercial production ramp-up.

Patrys Limited has announced a fully underwritten entitlement offer to raise approximately $1.77 million, aimed at funding ongoing research and development of its PAT-DX3 therapy and supporting working capital. The offer includes secondary options and shares, subject to shareholder approval, and will significantly expand the company's capital base.